Singapore markets closed

Blueprint Medicines Corporation (BPMC)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
86.35-2.55 (-2.87%)
As of 01:18PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts15151515
Avg. Estimate-1.66-1.48-5.55-2.78
Low estimate-1.8-1.63-6.28-6.46
High estimate-1.46-1.22-4.37-0.27
Year ago EPS-2.15-2.19-8.37-5.55
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts15151616
Avg. Estimate80.91M92.68M392.98M596.03M
Low estimate72M87M372M481.18M
High estimate86.7M103M449M738.9M
Year ago sales63.29M45.47M249.38M392.98M
Sales growth (year/est)27.80%103.80%57.60%51.70%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-2.67-2.54-2.37-2.04
Actual EPS-2.15-2.19-2.2-1.82
Difference0.520.350.170.22
Surprise %19.50%13.80%7.20%10.80%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-1.66-1.48-5.55-2.78
7 days ago-1.66-1.48-5.55-2.78
30 days ago-1.66-1.48-5.55-2.78
60 days ago-1.67-1.48-5.54-2.77
90 days ago-1.72-1.44-5.42-3.05
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 days1N/A1N/A
Up last 30 days1N/A1N/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesBPMCIndustrySector(s)S&P 500
Current qtr.22.80%N/AN/AN/A
Next qtr.32.40%N/AN/AN/A
Current year33.70%N/AN/AN/A
Next year49.90%N/AN/AN/A
Next 5 years (per annum)-92.01%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A